PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant Therapy

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.330
https://www.valueinhealthjournal.com/article/S1098-3015(11)01892-4/fulltext
Title : PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant Therapy
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01892-4&doi=10.1016/j.jval.2011.08.330
First page : A291
Section Title : Mental Health
Open access? : No
Section Order : 304
Categories :
Tags :
Regions :
ViH Article Tags :